What is the clinical evidence from this study?

Study design: Review. Population: Acute dyspnea and emergency conditions. Intervention: Point-of-care testing of BNP and NT-proBNP.

What question did this study set out to answer?

To evaluate the diagnostic utility, physiological mechanisms, and clinical limitations of point-of-care brain natriuretic peptide testing in acute emergency care.

January 1, 2014International Journal of Critical Illness and Injury ScienceOpen Access

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department

View Full Paper

Ask AI

Bookmark

Key result

Point-of-care testing of BNP and NT-proBNP assists emergency physicians in rapidly diagnosing heart failure, differentiating it from other causes of dyspnea, and prognosticating various critical conditions.

Population

Patients presenting to the emergency department with acute conditions such as undifferentiated dyspnea…

Design

Review

Authors

PAPraveen AggarwalNational Institute of Technology Kurukshetra NJNayer JamshedAll India Institute of Medical Sciences SGSagar GalwankarFlorida State University

Discussion

Member takes

Implication

Supports ED dyspnea evaluation with POC natriuretic peptides; leaves open need for RCTs on outcomes and cost-effectiveness.

Key Points

To evaluate the diagnostic utility, physiological mechanisms, and clinical limitations of point-of-care brain natriuretic peptide testing in acute emergency care.
Narrative review examining the structural and physiological differences between active brain natriuretic peptide (BNP) and inert N-terminal pro-brain natriuretic peptide (NT-proBNP).
Synthesis of clinical applications for emergency triage, dyspnea differential diagnosis, and management of systemic non-cardiac conditions.
Point-of-care BNP and NT-proBNP measurements provide rapid risk stratification and distinguish cardiac-related dyspnea from pulmonary causes.
Plasma concentrations are substantially influenced by patient age, body weight, assay type, and concurrent pathologies including chronic renal failure, diabetes, and sepsis.

Structured PICO

Population

Patients presenting to the emergency department with acute conditions such as undifferentiated dyspnea, heart failure, coronary artery disease, sepsis, and renal failure.

Intervention

Point-of-care testing of natriuretic peptides (BNP and NT-proBNP)

Point-of-care testing of BNP and NT-proBNP is highly useful in the emergency department for diagnosing heart failure and risk-stratifying patients with various acute conditions.

Limitations

Values of natriuretic peptides are affected by age, weight, and comorbidities such as chronic renal failure, diabetes, and anemia.
Values vary depending on the type of test used.
Determination of reference values for these peptides represents a challenge.

Cite This Study

Aggarwal et al. (2014) conducted a review in Acute dyspnea and emergency conditions. Point-of-care testing of BNP and NT-proBNP was evaluated. Point-of-care testing of BNP and NT-proBNP assists emergency physicians in rapidly diagnosing heart failure, differentiating it from other causes of dyspnea, and prognosticating various critical conditions.

synapsesocial.com/papers/6a0efd6db7cc3b883f22f551 https://doi.org/10.4103/2229-5151.141406

Topics

HFrEF treatment Heart failure

View Full Paper

Ask AI

Bookmark

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Topics

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider